Publications

TDMR Europe webinar - July 2020

TDMR Europe – ‘Reducing future risk: Obesity co-morbidities and nutritional status’ – INDEX PAGE

4th August 2020

Total Diet & Meal Replacements Europe (TDMR Europe)’s webinar, ‘Reducing future risk: Obesity co-morbidities and nutritional status’, attracted over 100 academics, policymakers and medical specialists from all over the world. The webinar, which had been awarded SCOPE World Obesity Federation accreditation, highlighted the use of total diet replacements to reduce

Read More...

‘Obesity, nutritional status and COVID-19’ – Carel Le Roux

31st July 2020

Prof Carel le Roux, Diabetes Complications Research Centre, University College Dublin, Ireland People with obesity are one of the high risk groups to develop severe illness from COVID-19. Several diseases have been associated with COVID-19 hospitalizations but consistently the severity of COVID-19 corelates with BMI. Obesity increases  the risk of

Read More...

‘TDR to achieve diabetes remission and diabetes risk reduction’ – Mike Lean

4th August 2020

Mike Lean, University of Glasgow Type 2 diabetes (T2D) affects nearly 4 million UK people, previously considered permanent and inevitably progressive, with disabling, life-shortening complications.  It accounts for ~10% of total healthcare expenditure across Europe.  It is caused by adult weight gain in people with family/genetic predispositions.  The Diabetes Remission

Read More...

‘TDR and vitamin D status in elderly obese people with knee osteoarthritis’ – Henning Bliddal

4th August 2020

Henning Bliddal, Parker Institute, Frederiksburg Hospital, Copenhagen, Denmark Introduction: Among several comorbidities to obesity, osteoarthritis (OA) of the knee is increasingly important. Obesity and kneeOA are linked in several ways and form a vicious circle, each intensifying the other. As the populations grow older and heavier, both individuals and society

Read More...

‘Diabetes remission: research needs and translation into practice’ – Professor Shahrad Taheri

4th August 2020

Professor Shahrad Taheri The prevalence of obesity and its complications such as type 2 diabetes (T2D) is increasing worldwide. In particular, the Middle East and North Africa (MENA) region has one of the highest prevalence of obesity and T2D in the world with onset of both conditions at a younger

Read More...

Experts gather to discuss reducing risk of diabetes and cardiovascular disease in webinar hosted by TDMR Europe

24th July 2020

Total Diet & Meal Replacements Europe (TDMR Europe) yesterday (23 July 2020) delivered a webinar, ‘Reducing future risk: Obesity co-morbidities and nutritional status’, attracting over 100 academics, policymakers and medical specialists from all over the world. The webinar, which had been awarded SCOPE World Obesity Federation accreditation, highlighted the use

Read More...

Dublin Seminar - April 2019

The DiRECT diabetes remission trial – an interview with Mike Lean

10th June 2019

“Formula diets, as currently designed, have proved extremely safe and effective in helping people to lose substantial amounts of weight, and gaining remission of type-2 diabetes. Almost nine out of 10 people with type-2 diabetes were still in remission, not diabetic and not needing medications, a year later if they

Read More...

Joe McSorley – a diabetes remission success story

27th June 2019

“While the total diet replacement is not a cure, it can put type 2 diabetes in remission, what happens after that is down to will power and lots of hard work in the gym to maintain the weight loss. In truth, it is a lifestyle change but one that for

Read More...

Henning Bliddal on Osteoarthritis: weight loss is key to improvement

14th August 2019

“Obesity is widely acknowledged as a risk factor for both the incidence and progression of osteoarthritis and has a negative influence on outcomes. Loss of at least 10% of body weight, coupled with exercise, is recognised as a cornerstone in the management of obese patients with osteoarthritis, and can lead

Read More...

Obesity: disease or lifestyle choice? An interview with Carel Le Roux

14th June 2019

“We now treat obesity like all other chronic diseases, and we understand the value of meal replacement strategies which helps change the symptoms of hunger and lack of satiety in a subpopulation of people with the disease of obesity. For these people losing weight is effortless as the meal replacements

Read More...

An interview with Professor Anthony Leeds

28th May 2019

In this exclusive interview, Professor Anthony Leeds discusses the benefits of formula food diets (TDRs and MRPs) at our recent seminar ‘Healthcare cost reduction and improved quality of life with evidence-based weight loss in diabetes and osteoarthritis’ at University College Dublin. The event, delivered in partnership with The World Obesity

Read More...

Dr Nerys Astbury: the future of TDRs

8th July 2019

  “The DROPLET trial showed that after 12 months people on total diet replacements lost on average 10.7kg (1 stone, 9lb), which was 7.2kg (1 stone, 1 lb) more than those only receiving the standard nurse-led programme of weight loss advice. This new analysis adds to that finding by strongly

Read More...

Seamus Kent: the DROPLET study

15th July 2019

“Studies like ours, which provide reliable estimates of the long-term impacts of weight management programmes on patients’ health and healthcare costs, are of real importance to enable the NHS to select the most clinically and cost-effective services for their patients.”[1] Seamus Kent, health economist at the University of Oxford, presents

Read More...

Mikael Fogelholm: Diabetes prevention and remission

1st August 2019

“The PREVIEW-study is one of the largest and longest randomized interventions to study the effects of diet and physical activity prevention of type 2 diabetes in pre-diabetic individuals. Compared to earlier studies, the use of a total diet replacement strategy during the first two months was a new element. The

Read More...